InsiderClue
Insiders · Profile

Invus Public Equities, L.P.

10% owner at Scholar Rock · 10% owner at CRESCENT BIOPHARMA · 10% owner at Seer · and 1 more. Filing since 10 Nov 2017. CIK 0001340097

SRRK Scholar Rock Holding Corp 10% owner · 9 trades CBIO CRESCENT BIOPHARMA, INC. 10% owner · 17 trades SEER Seer, Inc. 10% owner · 2 trades LXRX LEXICON PHARMACEUTICALS, INC. Director · 27 trades
Company
Date
Role
Action
Shares
Amount
Of holding
SRRK Scholar Rock Holding Corp
10 Dec 2024
10% owner
Sold at will
1,600,000
$66.64M
14.7%
SRRK Scholar Rock Holding Corp
25 Nov 2024
10% owner
Sold at will
409,433
$15.76M
3.6%
CBIO CRESCENT BIOPHARMA, INC.
8 Aug 2024
10% owner
Sold at will
260,873
$50.01K
4.0%
CBIO CRESCENT BIOPHARMA, INC.
7 Aug 2024
10% owner
Sold at will
61,488
$11.20K
0.9%
CBIO CRESCENT BIOPHARMA, INC.
6 Aug 2024
10% owner
Sold at will
55,732
$10.19K
0.8%
CBIO CRESCENT BIOPHARMA, INC.
5 Aug 2024
10% owner
Sold at will
164,523
$31.00K
2.4%
CBIO CRESCENT BIOPHARMA, INC.
2 Aug 2024
10% owner
Sold at will
286,200
$57.35K
4.0%
CBIO CRESCENT BIOPHARMA, INC.
1 Aug 2024
10% owner
Sold at will
63,564
$13.74K
0.9%
CBIO CRESCENT BIOPHARMA, INC.
30 Jul 2024
10% owner
Sold at will
756,835
$167.18K
9.5%
CBIO CRESCENT BIOPHARMA, INC.
29 Jul 2024
10% owner
Sold at will
363,949
$85.64K
4.4%
CBIO CRESCENT BIOPHARMA, INC.
26 Jul 2024
10% owner
Sold at will
258,335
$62.44K
3.0%
SRRK Scholar Rock Holding Corp
12 Oct 2023
10% owner
Bought
2,199,931
$15.09M
24.3%
SRRK Scholar Rock Holding Corp
28 Apr 2023
10% owner
Bought
31,557
$202.85K
0.3%
CBIO CRESCENT BIOPHARMA, INC.
24 Feb 2023
10% owner
Bought
100,000
$170.00K
1.2%
CBIO CRESCENT BIOPHARMA, INC.
23 Feb 2023
10% owner
Bought
200,000
$350.76K
2.4%
CBIO CRESCENT BIOPHARMA, INC.
22 Feb 2023
10% owner
Bought
150,000
$269.00K
1.8%
CBIO CRESCENT BIOPHARMA, INC.
21 Feb 2023
10% owner
Bought
50,000
$92.50K
0.6%
CBIO CRESCENT BIOPHARMA, INC.
17 Feb 2023
10% owner
Bought
200,000
$341.00K
2.5%
CBIO CRESCENT BIOPHARMA, INC.
16 Feb 2023
10% owner
Bought
315,266
$531.13K
4.2%
CBIO CRESCENT BIOPHARMA, INC.
15 Feb 2023
10% owner
Bought
1,000,000
$2.16M
15.2%
CBIO CRESCENT BIOPHARMA, INC.
9 Feb 2023
10% owner
Bought
11,451
$37.12K
0.2%
SRRK Scholar Rock Holding Corp
9 Jan 2023
10% owner
Sold, plan not stated
1,094
$10.37K
0.0%
SRRK Scholar Rock Holding Corp
5 Jan 2023
10% owner
Bought
48,774
$455.09K
0.5%
SRRK Scholar Rock Holding Corp
25 Oct 2022
10% owner
Bought
130,265
$1.05M
1.5%
SRRK Scholar Rock Holding Corp
4 Oct 2022
10% owner
Bought
66,000
$520.76K
0.8%
SRRK Scholar Rock Holding Corp
3 Oct 2022
10% owner
Bought
33,971
$238.79K
0.4%
SEER Seer, Inc.
1 Feb 2021
10% owner
Sold, plan not stated
252,545
$16.20M
4.3%
LXRX LEXICON PHARMACEUTICALS, INC.
16 Dec 2020
Director
Bought
10,937,500
$35.00M
51.3%
SEER Seer, Inc.
8 Dec 2020
10% owner
Bought
790,000
$15.01M
15.6%
LXRX LEXICON PHARMACEUTICALS, INC.
28 Jun 2018
Director
Bought
57,724
$718.94K
1.7%
LXRX LEXICON PHARMACEUTICALS, INC.
27 Jun 2018
Director
Bought
125,114
$1.57M
3.8%
LXRX LEXICON PHARMACEUTICALS, INC.
25 Jun 2018
Director
Bought
228,264
$2.96M
7.4%
LXRX LEXICON PHARMACEUTICALS, INC.
22 Jun 2018
Director
Bought
25,461
$340.09K
0.8%
LXRX LEXICON PHARMACEUTICALS, INC.
21 Jun 2018
Director
Bought
51,600
$684.61K
1.7%
LXRX LEXICON PHARMACEUTICALS, INC.
20 Jun 2018
Director
Bought
12,391
$164.61K
0.4%
LXRX LEXICON PHARMACEUTICALS, INC.
19 Jun 2018
Director
Bought
8,982
$120.82K
0.3%
LXRX LEXICON PHARMACEUTICALS, INC.
18 Jun 2018
Director
Bought
36,584
$477.94K
1.2%
LXRX LEXICON PHARMACEUTICALS, INC.
14 Jun 2018
Director
Bought
9,200
$116.46K
0.3%
LXRX LEXICON PHARMACEUTICALS, INC.
12 Jun 2018
Director
Bought
107,023
$1.37M
3.8%
LXRX LEXICON PHARMACEUTICALS, INC.
11 Jun 2018
Director
Bought
98,626
$1.26M
3.6%
LXRX LEXICON PHARMACEUTICALS, INC.
8 Jun 2018
Director
Bought
29,747
$383.43K
1.1%
LXRX LEXICON PHARMACEUTICALS, INC.
7 Jun 2018
Director
Bought
57,439
$742.51K
2.2%
LXRX LEXICON PHARMACEUTICALS, INC.
6 Jun 2018
Director
Bought
95,079
$1.20M
3.7%
LXRX LEXICON PHARMACEUTICALS, INC.
5 Jun 2018
Director
Bought
173,121
$2.16M
7.2%
LXRX LEXICON PHARMACEUTICALS, INC.
4 Jun 2018
Director
Bought
121,803
$1.49M
5.3%
LXRX LEXICON PHARMACEUTICALS, INC.
1 Jun 2018
Director
Bought
147,339
$1.80M
6.9%
LXRX LEXICON PHARMACEUTICALS, INC.
31 May 2018
Director
Bought
147,339
$1.71M
7.4%
LXRX LEXICON PHARMACEUTICALS, INC.
30 May 2018
Director
Bought
147,339
$1.52M
8.0%
LXRX LEXICON PHARMACEUTICALS, INC.
29 May 2018
Director
Bought
147,339
$1.45M
8.7%
LXRX LEXICON PHARMACEUTICALS, INC.
25 May 2018
Director
Bought
138,700
$1.33M
8.9%
LXRX LEXICON PHARMACEUTICALS, INC.
17 Nov 2017
Director
Bought
50,000
$492.50K
3.3%
LXRX LEXICON PHARMACEUTICALS, INC.
15 Nov 2017
Director
Bought
130,727
$1.33M
9.5%
LXRX LEXICON PHARMACEUTICALS, INC.
14 Nov 2017
Director
Bought
215,133
$2.04M
18.6%
LXRX LEXICON PHARMACEUTICALS, INC.
13 Nov 2017
Director
Bought
215,133
$2.10M
22.9%
LXRX LEXICON PHARMACEUTICALS, INC.
10 Nov 2017
Director
Bought
145,680
$1.42M
18.4%
55 decisions on file.